VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

10680	Companies
228005	Keywords
156514	Articles
120875	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 12/18/2025 at 17:40, 6 months 17 days ago

VALBIOTIS SA: Valbiotis distingué par le prix Top Santé 2025 pour Valbiotis Plus® Sérénité, solution innovante pour l’équilibre émotionnel
Valbiotis reçoit le prix Top Santé 2025 pour Valbiotis Plus® Sérénité, innovante pour l’équilibre émotionnel. Distinction basée sur critères d'efficacité, santé, éthique et innovation

Innovation Valbiotis Santé Équilibre Émotionnel Prix Top Santé 2025
BRIEF

published on 12/08/2025 at 17:45, 6 months 27 days ago

Valbiotis finalise le recrutement pour l'étude cardio-hépatique avec TOTUM•448

Valbiotis Étude Clinique MASLD Essai CARDIO-FOIE TOTUME•448
BRIEF

published on 12/08/2025 at 17:45, 6 months 27 days ago

Valbiotis Completes Recruitment for Cardio-Liver Study with TOTUM•448

Valbiotis Clinical Study MASLD CARDIO-LIVER Trial TOTUM•448
BRIEF

published on 12/08/2025 at 17:45, 6 months 27 days ago

Valbiotis: Recruitment closed for the Cardio-Liver study

Valbiotis Clinical Study TOTUM-448 Cardio-Liver MALSD
BRIEF

published on 12/08/2025 at 17:45, 6 months 27 days ago

Valbiotis : Clôture du recrutement pour l'étude Cardio-Liver

Valbiotis Étude Clinique TOTUM-448 Cardio-Liver MALSD
PRESS RELEASE

published on 12/08/2025 at 17:40, 6 months 27 days ago

VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
Valbiotis announces completion of recruitment for the Cardio-Liver clinical study with TOTUM•448 for metabolic liver diseases. Results expected in 2026

Valbiotis Clinical Study Cardio-Liver TOTUM•448 Metabolic Liver Diseases
PRESS RELEASE

published on 12/08/2025 at 17:40, 6 months 27 days ago

VALBIOTIS SA: Valbiotis annonce la fin du recrutement de l’étude clinique Cardio-Liver conduite avec TOTUM-448 pour les maladies métaboliques du foie (MASLD)
Valbiotis annonce la fin du recrutement de l'étude clinique Cardio-Liver avec TOTUM-448 pour les maladies métaboliques du foie (MASLD). Résultats disponibles en 2026

Valbiotis Étude Clinique MASLD TOTUM-448 Maladies Métaboliques Du Foie
BRIEF

published on 11/25/2025 at 14:05, 7 months 9 days ago

Valbiotis : Informations mensuelles sur les droits de vote et actions

Droits De Vote Capital Social Euronext Growth Réglementation Valbiotis
BRIEF

published on 11/25/2025 at 14:05, 7 months 9 days ago

Valbiotis: Monthly information on voting rights and shares

Share Capital Voting Rights Euronext Growth Regulation Valbiotis
BRIEF

published on 11/25/2025 at 14:05, 7 months 9 days ago

Valbiotis : Informations sur le Capital Social et les Droits de Vote

Droits De Vote Capital Social Euronext Growth Valbiotis Réglementation AMF

Accesswire

Published on 07/03/2026 at 23:00, 23 hours 40 minutes ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 23 hours 40 minutes ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 1 day 1 hour ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 1 day 3 hours ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 9 hours ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/04/2026 at 17:35, 5 hours 5 minutes ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 11 hours 39 minutes ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 13 hours 35 minutes ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 1 day 3 hours ago

PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 1 day 3 hours ago

Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development

Les Echos

Published on 07/03/2026 at 21:49, 1 day ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 1 day ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 1 day 3 hours ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 1 day 3 hours ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 1 day 4 hours ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE